1. Epigenetic Modification of MicroRNA-200b Contributes to Diabetic Vasculopathy
- Author
-
Surya Gnyawali, Durba Pal, Savita Khanna, Subhadip Ghatak, Sashwati Roy, Chandan K. Sen, Kanhaiya Singh, and Mithun Sinha
- Subjects
0301 basic medicine ,Methyltransferase ,Angiogenesis ,Mice, Transgenic ,Biology ,Cell Line ,DNA Methyltransferase 3A ,Diabetes Mellitus, Experimental ,Epigenesis, Genetic ,03 medical and health sciences ,Mice ,Downregulation and upregulation ,Stable isotope labeling by amino acids in cell culture ,Drug Discovery ,microRNA ,Genetics ,Animals ,Humans ,Promoter Regions, Genetic ,Selenomethionine ,Molecular Biology ,Pharmacology ,Tube formation ,Matrigel ,Neovascularization, Pathologic ,Endothelial Cells ,DNA Methylation ,Cell biology ,Disease Models, Animal ,MicroRNAs ,030104 developmental biology ,Biochemistry ,Gene Expression Regulation ,Hyperglycemia ,DNA methylation ,Molecular Medicine ,Original Article ,Diabetic Angiopathies - Abstract
Hyperglycemia (HG) induces genome-wide cytosine demethylation. Our previous work recognized miR-200b as a critical angiomiR, which must be transiently downregulated to initiate wound angiogenesis. Under HG, miR-200b downregulation is not responsive to injury. Here, we demonstrate that HG may drive vasculopathy by epigenetic modification of a miR promoter. In human microvascular endothelial cells (HMECs), HG also lowered DNA methyltransferases (DNMT-1 and DNMT-3A) and compromised endothelial function as manifested by diminished endothelial nitric oxide (eNOS), lowered LDL uptake, impaired Matrigel tube formation, lower NO production, and compromised VE-cadherin expression. Bisulfite-sequencing documented HG-induced miR-200b promoter hypomethylation in HMECs and diabetic wound-site endothelial cells. In HMECs, HG compromised endothelial function. Methyl donor S-adenosyl-L-methionine (SAM) corrected miR-200b promoter hypomethylaton and rescued endothelial function. In vivo, wound-site administration of SAM to diabetic mice improved wound perfusion by limiting the pathogenic rise of miR-200b. Quantitative stable isotope labeling by amino acids in cell culture (SILAC) proteomics and ingenuity pathway analysis identified HG-induced proteins and principal clusters in HMECs sensitive to the genetic inhibition of miR-200b. This work presents the first evidence of the miR-200b promoter methylation as a critical determinant of diabetic wound angiogenesis.
- Published
- 2017